FY2025 · ended Dec 31, 2025 · Revenue $13.64B, +6.5% YoY · Filed Feb 11, 2026
Davita Inc. (DVA) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $13.6 billion and net income of $746.8 million. Free cash flow was $1.3 billion. As of Sep 30, 2026 it held $604.7 million in cash and investments and $13.3 billion in total debt.
Revenue (TTM)
$14.17B
+6.4% vs year-ago TTM
Net income (TTM)
$920.08M
+19.2% vs year-ago TTM
Operating cash flow (TTM)
$1.87B
-1.2% vs year-ago TTM
Free cash flow (TTM)
$1.29B
+0.1% vs year-ago TTM
EPS (TTM)
$13.54
+38.7% vs year-ago TTM
Dividend per share
None
Shares outstanding
66.80M
-16.5% vs prior year
Net cash
$-12.68B
as of Sep 30, 2026
Operating margin
15.0%
FY 2026
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- DVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927066
- Former names
- DAVITA HEALTHCARE PARTNERS INC. (until Aug 12, 2016); DAVITA INC (until Nov 2, 2012); TOTAL RENAL CARE HOLDINGS INC (until Jan 28, 2000)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $13.6B | $12.8B | $12.1B | $11.6B | $11.6B |
| Operating income | $2.0B | $2.1B | $1.6B | $1.3B | $1.8B |
| Net income | $746.8M | $936.3M | $691.5M | $560.4M | $978.5M |
| Diluted EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Operating cash flow | $1.9B | $2.0B | $2.1B | $1.6B | $1.9B |
| Free cash flow | $1.3B | $1.5B | $1.5B | $961.1M | $1.3B |
| Total assets | $17.5B | $17.3B | $16.9B | $16.9B | $17.1B |
| Total liabilities | $16.3B | $15.2B | $14.2B | $14.7B | $14.8B |
| Stockholders' equity | -$651.1M | $121.1M | $1.1B | $712.3M | $755.5M |
| Cash and investments | $741.7M | $879.7M | $439.6M | $366.1M | $533.7M |
| Total debt | $12.8B | $11.8B | $11.0B | $11.6B | $11.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
All 1001 Davita Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.